Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 36 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10940188

    Compounds and methods for treatment and prevention of Flavivirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  2. US 10933042

    Intravenous baclofen formulations and treatment methods

    Regents of the University of Minnesota · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  3. US 10933066

    Methods and compositions for treatment of Zika virus infection

    BioCryst Pharmaceuticals, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  4. US 10928391

    CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  5. US 10927088

    Thymoquinone derivatives for treatment of cancer

    UNITED ARAB EMIRATES UNIVERSITY · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  6. US 10927435

    Compositions for the treatment of rheumatoid arthritis and methods of using same

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  7. US 10918657

    Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation

    The Board of Regents of the University of Texas System · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  8. US 10918594

    Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  9. US 10913740

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Theravance Biopharma R&D IP, LLC · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  10. US 10913947

    Antisense oligomers for treatment of conditions and diseases

    STOKE THERAPEUTICS, INC. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  11. US 10913946

    RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy

    BIOMARIN TECHNOLOGIES B.V. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  12. US 10912834

    Topical formulations based on ionic species for skin treatment

    The Regents of the University of California · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  13. US 10905690

    Treatment of congenital adrenal hyperplasia

    Neurocrine Biosciences, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  14. US 10906928

    Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

    Atea Pharmaceuticals, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  15. US 10905770

    Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseases

    MacRegen, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  16. US 10899710

    Pyridines and their use in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  17. US 10898505

    Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

    Benitec Biopharma Limited · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  18. AU 2019273664

    Methods for the treatment of psoriatic arthritis

    ALFASIGMA SPA [IT] · Granted Jan 21, 2021 · Expires Jan 16, 2041

    granted
  19. US 10894804

    Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

    Atea Pharmaceuticals, Inc. · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted
  20. US 10894077

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted
  21. US 10894044

    Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted
  22. US 10889576

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  23. US 10888554

    Salts of heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  24. US 10881698

    Diagnosis and treatment for respiratory tract diseases

    United States Government as represented by the Department of Veterans Affairs · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted